Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory
2006
Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida
1987
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Fluconazole Penetration into Cerebrospinal Fluid: Implications for Treating Fungal Infections of the Central Nervous System
1988
Spectrum of Cryptococcus neoformans Infection in 68 Patients Infected with Human Immunodificiency Virus
1990
Flucytosine therapeutic monitoring: 15 years experience from the UK
2007
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
2000
Vulvovaginal candidosis
2007 Standout
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Candida Urinary Tract Infections—Diagnosis
2011
Cryptococcal Meningitis: Outcome in Patients with AIDS and Patients with Neoplastic Disease
1992
Bladder Irrigation with Amphotericin B for Treatment of Fungal Urinary Tract Infections
1994
CNS pharmacokinetics of antifungal agents
2007
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Experience with itraconazole in cryptococcosis and aspergillosis
1989
Cryptococcal Pneumonia Complicating Pregnancy
1998
Measurement of Cryptococcal Antigen in Serum and Cerebrospinal Fluid: Value in the Management of AIDS-Associated Cryptococcal Meningitis
1994
Marine natural products
1990 Standout
Cushing's syndrome
2015 Standout
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients
1988
Improved Amphotericin B Activity by a Monoclonal Anti-Cryptococcus neoformans Antibody: Study during Murine Cryptococcosis and Mechanisms of Action
1991
Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy
1992
Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
2004 Standout
Cryptococcal Skeletal Infections: Case Report and Review
1990
Fluconazole Compared with Amphotericin B plus Flucytosine for Cryptococcal Meningitis in AIDS
1990
Candida parapsilosis: Epidemiology, Pathogenicity, Clinical Manifestations, and Antimicrobial Susceptibility
1992
Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing
1996
Candida Urinary Tract Infection: Pathogenesis
2011
Fluconazole monotherapy for cryptococcosis in non-AIDS patients
1996
Correlation of In Vitro Azole Susceptibility with In Vivo Response in a Murine Model of Cryptococcal Meningitis
1993
Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome
2001
Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats
1998
Primary Renal Candidiasis
2009
Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients
2000
Fluconazole Therapy for Experimental Cryptococcosis and Candidiasis in the Rabbit
1990
Cryptococcosis in Organ Transplant Recipients: An Overview
2002
Persistent Cryptococcus neoformans Infection of the Prostate after Successful Treatment of Meningitis
1989
Candida Urinary Tract Infections—Treatment
2011
Antifungal Therapy During Pregnancy
1998
A Placebo-Controlled Trial of Maintenance Therapy with Fluconazole after Treatment of Cryptococcal Meningitis in the Acquired Immunodeficiency Syndrome
1991
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
Treatment of Mycoses with Itraconazole
1988
Clearance of Funguria with Short-Course Antifungal Regimens: A Prospective, Randomized, Controlled Study
1995
Yeast in the Urine: Solutions for a Budding Problem
1995
Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS
1994
Cryptococcosis
2006
Treatment of invasive aspergillosis with itraconazole
1989
Sex differences in trauma and posttraumatic stress disorder: A quantitative review of 25 years of research.
2006 Standout
Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis
1992
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
2001
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
Cryptococcal Meningitis and AIDS
1993
Adenovirus-Mediated Blockade Of Tumor Necrosis Factor In Mice Protects Against Endotoxic Shock Yet Impairs Pulmonary Host Defense
1995 StandoutNobel
Echinocandin antifungal drugs
2003 Standout
Drug resistance in human pathogenic fungi
1992
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
Candida Urinary Tract Infections—Epidemiology
2011
The Diels-Alder Reaction in Total Synthesis
2002 Standout
Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo
2000
Infections in Patients with Diabetes Mellitus
1999 Standout
Opportunistic Fungi: A View to the Future
2010
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates
1990
Candidiasis
1989
Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. I. Isolation and biological properties.
1992
Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole Therapy
2001
Comparison of the Efficacy of Amphotericin B and Fluconazole in the Treatment of Cryptococcosis in Human Immunodeficiency Virus-Negative Patients: Retrospective Analysis of 83 Cases
1996
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
2007
Cryptococcosis and Idiopathic CD4 Lymphocytopenia
2007
Antifungal Agents in Children
2005
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout
Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen
1994
The Poor Prognosis of Central Nervous System Cryptococcosis among Nonimmunosuppressed Patients: A Call for Better Disease Recognition and Evaluation of Adjuncts to Antifungal Therapy
2006
Candiduria in critically ill patients admitted to intensive care medical units
2003
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea
1996
New drugs for systemic fungal infections.
1989
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
1997
Immunity to fungal infections
2011 Standout
Emerging fungal threats to animal, plant and ecosystem health
2012 StandoutNature
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Amphotericin B: 30 Years of Clinical Experience
1990
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Management of cryptococcosis in non-HIV-related patients
2004
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Projecting Global Occurrence ofCryptococcus gattii
2009
Infection in Organ-Transplant Recipients
1998 Standout
Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome
1995
Management of Cryptococcosis
1993
Acute Ureteral Colic from an Obstructing Renal Aspergilloma
1987
Antifungal activities of origanum oil against Candida albicans
2001
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Probing the N-5 Region of the Indoloquinoline Alkaloid, Cryptolepine for Anticryptococcal Activity
1999
Biological effects of essential oils – A review
2007 Standout
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
2004
CNS pharmacokinetics of antifungal agents
2007
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis
1997
Tissue Penetration of Amphotericin B in Candida Endocarditis
1974
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests
1992
A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection
1977 Standout
Pharmacology and toxicity of high-dose ketoconazole
1987
Detection of amphotericin B-resistant Candida isolates in a broth-based system
1995
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
1995
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Experimental aspergillus endocarditis in rabbits.
1975
Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes
1989 StandoutNobel
Efficacy of Amphotericin B in Combination with Flucytosine against Flucytosine-Susceptible or Flucytosine-Resistant Isolates of Cryptococcus neoformans during Disseminated Murine Cryptococcosis
2005
Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14α-sterol demethylase purified from Candida albicans
1990
Cryptococcal Meningitis: Complications Due to Intrathecal Treatment
1980
The Use of Ketoconazole as an Inhibitor of Steroid Production
1987
AGROACTIVE COMPOUNDS OF MICROBIAL ORIGIN
1993 StandoutNobel
Cryptococcosis (torulosis) of prostate
1981
Infection Control in Intravenous Therapy
1973 Standout
Candida rugosa in immunocompromised infection case reports, drug susceptibility, and review of the literature
1985
Penile cryptococcosis with review of mycotic infections of penis
1985
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
Candida Septic Thrombosis of the Great Central Veins Associated with Central Catheters
1985
Antifungal agents: chemotherapeutic targets and immunologic strategies
1996
Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera
1984
Failure of Ketoconazole in Cryptococcal Meningitis
1982
Cryptococcus neoformans: Comparisons of in vitro antifungal susceptibilities of serotypes AD and BC
1986
Activity of Orally, Topically, and Parenterally Administered Itraconazole in the Treatment of Superficial and Deep Mycoses: Animal Models
1987
Chemistry and biology of the polyene macrolide antibiotics.
1973
Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole
1993
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Invasive pulmonary aspergillosis after near-drowning
1984
Conazoles
2010
Initial Experience in Therapy for Progressive Mycoses with Itraconazole, the First Clinically Studied Triazole
1987
Intracranial infection in cardiac transplant recipients
1981
Oral dose and faecal concentration of antibiotics during antibiotic decontamination in mice and in a patient
1974
Combined Therapy with Amphotericin B and 5-Fluorocytosine for Candida Meningitis
1984
Strategies in the Treatment of Systemic Fungal Infections
1980
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts
1993
Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis Model
1983
Studies of patients in a laminar air flow unit
1969
Synergistic Action of Amphotericin Band Rifampin against Candida Species
1976
Bone-Marrow Transplantation
1975 Standout
Intraocular penetration of systemically administered antifungal agents
1985
Invasive Candidiasis
2015 Standout
5-fluorocytosine treatment of meningeal and pulmonary aspergillosis
1973
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States
1982
Amphotericin B in Cryptococcal Meningitis
1969
Itraconazole Therapy for Cryptococcal Meningitis and Cryptococcosis
1989
Tolerance to and Efficacy of Itraconazole in Treatment of Systemic Mycoses: Preliminary Results
1987
Cure of Aspergillus ustus Endocarditis on
1974
Total synthesis of natural (+)-ambruticin
1993
Stereoselective Cyclopropanation Reactions
2003 Standout
Antipurified-Protein-Derivative Antibody in Tuberculous Pleural Effusions
1990 StandoutNobel
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Protected Environments and Prophylactic Antibiotics
1973
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole
1994
Clinical Pharmacokinetics of Systemic Antifungal Drugs
1983
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
1999
Cryptococcal Endophthalmitis after Corneal Transplantation
1978
Chemotherapeutic Activity of 5-Fluorocytosine and Amphotericin B Against Candida albicans in Mice
1973
A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis
1979
Cryptococcal Septicemia Associated with Urologic Instrumentation in a Renal Allograft Recipient
1981
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits
1986
Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with Cryptococcosis
2006
Susceptibility testing of Cryptococcus neoformans: a microdilution technique
1992
Cryptococcal Skull Infection
1993
Comparison of commercial kits for detection of cryptococcal antigen
1994
FUNGAL INFECTIONS IN DIABETES
1995
Successful treatment of cryptococcal meningitis with intraventricular miconazole
1978
Combined Amphotericin B-Flucytosine Therapy in Aspergillus Pneumonia
1979
Solitary pulmonary nodule due to cryptococcus neoformans and mycobacterium tuberculosis
1985
Fluconazole, a New Antifungal Agent
1990
Systemic Antifungal Agents
1998
In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrata
1972
Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates
1982
Septicemia and total parenteral nutrition. Distinguishing catheter-related from other septic episodes.
1973
Antifungal Agents Useful in Therapy of Systemic Fungal Infections
1983
Sino‐Orbital and Cerebral Aspergillosis: Cure with Medical Therapy/Sino‐Orbital‐ und Zerebralaspergillose: Ausheilung durch medikamentöse Therapie
1987
Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis
1990
Treatment of Experimental Cryptococcal Meningitis with Amphotericin B, 5-Fluorocytosine, and Ketoconazole
1982
Itraconazole treatment of murine aspergillosis
1985
Resistance of Candida species to fluconazole
1995
Cryptococcal Intracerebral Mass Lesions
1981
Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates
1995
Treatment of Funguria
1992
Transition-Metal-Catalyzed Reactions in Heterocyclic Synthesis
2004 Standout
Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine
1977
Planning and Monitoring of Equivalence Studies
1990
Antifungal agents in neonatal systemic candidiasis
1995
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis
1991
Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans
2006
Diagnosis of invasive candidiasis by a dot immunobinding assay for Candida antigen detection
1993
Coccidioidomycosis in Renal Replacement Therapy
1982
Total synthesis of (+)-ambruticin S
2003
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard
1994
Combination Amphotericin B-Rifampin Therapy for Pulmonary Aspergillosis in a Leukemic Patient
1976
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
2008
Critical Care Medicine
1971 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Cryptococcosis, with Emphasis on the Significance of Isolation of Cryptococcus neoformans from the Respiratory Tract
1977
Amphotericin B as a Urologic Irrigant in the management of Noninvasive Candiduria
1982
Nosocomial infections and Secondary Infections in Sepsis
1989
Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 Patients
1983
Amphotericin B Colloidal Dispersion Combined with Flucytosine with or without Fluconazole for Treatment of Murine Cryptococcal Meningitis
1998
Works of Smith Shadomy being referenced
Evaluations of a Patient Isolator System
1965
Availability of active amphotericin B after filtration through membrane filters.
1977
In vitro and in vivo evaluation of antifungal agents
1989
Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six Weeks
1987
Fungus Balls of the Urinary Tract
1979
Detection of Candida Antigenemia by Counterimmunoelectrophoresis in Patients with Invasive Candidiasis
1979
Cryptococcal meningitis in pregnancy.
1983
Biochemical serogrouping of clinical isolates of Cryptococcus neoformans
1987
Growth of Candida in Casein Hydrolysate Solutions
1972
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B
1986
Cryptococcosis in renal transplant patients.
1977
Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B
1975
In vitro Susceptibility Studies with Oxiconazole (Ro 13–8996)
1984
Bioassay for Miconazole
1977
5-fluorocytosine in human candidiasis.
1970
Therapeutic Failures with Miconazole
1978
Antifungal Activity of 5-Fluorocytosine as Measured by Disk Diffusion Susceptibility Testing
1977
Comparison study of broth macrodilution and microdilution antifungal susceptibility tests
1991
Bioassay for Hamycin and Amphotericin B in Serum and Other Biological Fluids
1969
Further In Vitro Studies with 5-Fluorocytosine
1970
In Vitro Studies with 5-Fluorocytosine
1969
Urinary Tract Infections Due to Candida albicans
1982
New Method for Susceptibility Testing with Antifungal Agents
1975
Serotype B/C Cryptococcus neoformans isolated from patients in nonendemic areas
1982
ORAL NEOMYCIN AND THE HEALING OF COLONIC ANASTOMOSES IN THE RAT.
1964
In Vivo Susceptibility of Cryptococcus neoformans to Hamycin, Amphotericin B, and 5-Fluorocytosine
1970
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
1986
In-vitro studies with SF 86–327, a new orally active allylamine derivative
1985
Comparison of the in Vitro Antifungal Activities of Miconazole and a New Imidazole, R41,400
1978
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis
1987
Cryptococcal Pyelonephritis
1968
In Vitro Activity of 5-Fluorocytosine Against Candida and Torulopsis Species
1973
In vitro studies with R 51,211 (itraconazole)
1984
Evaluations of a Patient Isolator System
1965
In Vitro Studies with 5-Fluorocytosine
1969
In-vitroinhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and bay l 9139
1983
In Vitro Studies with Combinations of 5-Fluorocytosine and Amphotericin B
1975
Evaluations of a Patient Isolator System
1965
In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine.
1968
A comparison of bifonazole (bay h 4502) with clotrimazolein vitro
1982
Standardized susceptibility testing of fluconazole: an international collaborative study
1992
Near-Drowning Complicated by Brain Abscess due to Petriellidium boydii
1982
Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatography
1978
In Vivo Studies with Ambruticin in Murine Histoplasmosis
1978
Bioassay for Hamycin and Amphotericin B in Serum and Other Biological Fluids
1969